Rethinking Innovation in Drugs: A Pathway to Health for All

Journal of Law, Medicine and Ethics 51 (S2):16-20 (2023)
  Copy   BIBTEX

Abstract

This article discusses the misalignment of the drug innovation model in the US with broader societal goals. The paper calls for a reconfiguration of this model to prioritize the common good and ensure equitable access to health innovations. The article stresses the importance of adopting a mission-oriented approach to shape the drug market, including reforming intellectual property rights.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,438

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Shared Value Creation through Community Health Initiatives: A Social Innovation.Linda C. Rodriguez & Patsy G. Lewellyn - 2013 - Proceedings of the International Association for Business and Society 24:106-111.
Shared Value Creation through Community Health Initiatives: A Social Innovation.Linda C. Rodriguez & Patsy G. Lewellyn - 2013 - Proceedings of the International Association for Business and Society 24:106-111.
Inequalities and healthcare reform in Chile: equity of what?J. Burrows - 2008 - Journal of Medical Ethics 34 (9):e13-e13.
An Antiracist Health Equity Agenda for Education.Thalia González, Alexis Etow & Cesar De La Vega - 2022 - Journal of Law, Medicine and Ethics 50 (1):31-37.

Analytics

Added to PP
2024-03-05

Downloads
29 (#540,498)

6 months
29 (#105,761)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references